Dr. Major graduated from the Dartmouth Medical School in 1994. He works in Moody, ME and specializes in Internal Medicine. Dr. Major is affiliated with York Hospital.
Revere HealthWasatch Ear Nose Throat & Allergy 950 Medical Dr STE 103, Brigham City, UT 84302 8778660170 (phone), 8018660169 (fax)
Revere HealthWasatch Ear Nose Throat & Allergy 5896 S Ridgeline Dr STE B, Ogden, UT 84405 8018660170 (phone), 8018660169 (fax)
Education:
Medical School University of Utah School of Medicine Graduated: 1996
Procedures:
Myringotomy and Tympanotomy Rhinoplasty Sinus Surgery Skull/Facial Bone Fractures and Dislocations Allergen Immunotherapy Allergy Testing Hearing Evaluation Tonsillectomy or Adenoidectomy Tympanoplasty
Dr. Major graduated from the University of Utah School of Medicine in 1996. He works in Ogden, UT and 1 other location and specializes in Otolaryngology and Allergy. Dr. Major is affiliated with Brigham City Community Hospital, Intermountain McKay-Dee Hospital Center and Ogden Regional Medical Center.
Southern Utah Neurosciences Institute 652 S Medical Ctr Dr STE 420, Saint George, UT 84790 4352516800 (phone), 4352516801 (fax)
Education:
Medical School Creighton University School of Medicine Graduated: 1975
Procedures:
Spinal Fusion Spinal Surgery Arthrocentesis Spinal Cord Surgery
Conditions:
Fractures, Dislocations, Derangement, and Sprains Internal Derangement of Knee Cartilage Intervertebral Disc Degeneration Osteoarthritis Osteomyelitis
Languages:
English Spanish
Description:
Dr. Major graduated from the Creighton University School of Medicine in 1975. He works in Saint George, UT and specializes in Orthopaedic Surgery. Dr. Major is affiliated with Dixie Regional Medical Center River Road Campus and Valley View Medical Center.
University Oklahoma Health Center-Anesthesia 750 NE 13 St STE 200, Oklahoma City, OK 73104 4052714351 (phone), 4052718695 (fax)
Education:
Medical School Oklahoma State University Center for Health Sciences College of Osteopathic Medicine Graduated: 1982
Languages:
English
Description:
Dr. Major graduated from the Oklahoma State University Center for Health Sciences College of Osteopathic Medicine in 1982. He works in Oklahoma City, OK and specializes in Anesthesiology. Dr. Major is affiliated with OU Medical Center Edmond and OU Medical Center The Childrens Hospital.
Robert Costa - Oak Park IL, US Pradip Raychaudhuri - Oak Park IL, US I-Ching Wang - Chicago IL, US Vladimir Kalinichenko - Clarendon Hills IL, US Michael Major - Chicago IL, US Xinhe Wang - Upper Arlington OH, US
Assignee:
The Board of Trustees of the University of Illinois - Urbana IL
International Classification:
A01N 37/18
US Classification:
514 2, 435 723
Abstract:
The invention provides methods for inhibiting tumor cell proliferation by inhibiting FoxM1B activity, expression, or nuclear localization in a tumor cell. The invention also provides methods for preventing tumor progression in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization. Furthermore, the invention provides methods for inhibiting tumor cell growth in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization in tumor cells in the animal.
Robert Costa - Oak Park IL, US Pradip Raychaudhuri - Oak Park IL, US Xinhe Wang - Upper Arlington OH, US Vladimir Kalinichenko - Clarendon Hills IL, US Michael Major - Chicago IL, US I-Ching Wang - Chicago IL, US
Assignee:
The Board of Trustees of the University of Illinois - Urbana IL
International Classification:
C07K 5/00 C07K 14/00
US Classification:
530300, 530350, 530333
Abstract:
The invention provides methods for inhibiting tumor cell proliferation by inhibiting FoxM1B activity, expression, or nuclear localization in a tumor cell. The invention also provides methods for preventing tumor progression in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization. Furthermore, the invention provides methods for inhibiting tumor cell growth in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization in tumor cells in the animal.
Michael D. Major - Evanston IL, US David W. Moore - Hebron IL, US
Assignee:
Rohm and Haas Company - Philadelphia PA
International Classification:
C07C 29/48
US Classification:
568704
Abstract:
Nitroaldol (“Henry”) reactions between nitroalkanes and aldehydes in the presence of a catalyst and a two-phase reaction medium produce nitroalcohols at increased reaction rates compared to single-phase organic solvent systems, and do not require use of surfactants as is typical of single-phase aqueous solvent systems and solventless systems. The reaction medium comprises an organic solvent phase and an aqueous solvent phase. The aqueous solvent may be 100% water.
Robert Costa - Oak Park IL, US Pradip Raychaudhuri - Oak Park IL, US Xinhe Wang - Chicago IL, US Vladimir Kalinichenko - Clarendon Hills IL, US Michael Major - Chicago IL, US I-Ching Wang - Cincinnati OH, US
Assignee:
The Board of Trustees of the University of Illinois - Urbana IL
International Classification:
A61K 35/12 A01N 61/00
US Classification:
514 11, 4242771
Abstract:
The invention provides methods for inhibiting tumor cell proliferation by inhibiting FoxM1B activity, expression, or nuclear localization in a tumor cell. The invention also provides methods for preventing tumor progression in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization. Furthermore, the invention provides methods for inhibiting tumor cell growth in an animal comprising inhibiting FoxM1B activity, expression, or nuclear localization in tumor cells in the animal.
Methods Of Treating Age-Related Defects And Diseases
Robert Costa - Oak Park IL, US Xinhe Wang - Upper Arlington OH, US Yongjun Tan - Arlington Heights IL, US Vladimir Kalinichenko - Clarendon Hills IL, US I-Ching Wang - Chicago IL, US Michael Major - Chicago IL, US
Assignee:
The Board of Trustees of the University of Illinois
International Classification:
A61K048/00 A61K038/18 A61K038/19 A61K038/20
US Classification:
424/085100, 424/085200, 514/012000, 514/044000
Abstract:
The invention provides a method of preventing or amelioriating age-related proliferation defects or age-related diseases in a patient by stimulating FoxM1B protein expression, nuclear localization, or both protein expression and nuclear localization of FoxM1B or by introducing a recombinant nucleic acid construct that comprises a truncated FoxM1B gene into target cells, thereby restoring proliferative potential of the target cells. The invention also provides a method of treating diseases or disorders associated with premature aging. The invention further provides a method of treating or ameliorating lung damage. Specifically, the methods of the invention comprise inducing expression and nuclear localization of FoxM1B protein in a target cell by contacting the cell with a growth factor or a cytokine.
Michael D. Major - Evanston IL Marion A. Dupre - East Haven CT
Assignee:
Kraft General Foods, Inc. - Glenview IL
International Classification:
A23L 124
US Classification:
426605
Abstract:
A mixing apparatus for viscous emulsions, and more particularly a mixing apparatus incorporating a pinned mixing chamber cooperating with splined rotor for the blending and homogenizing of at least one further constituent and/or air with a base emulsion received from a mixer in order to impart a specified and intended consistency and texture to a product produced from the emulsion. Furthermore, there is also provided a method for producing the product formulated from the viscous emulsion by utilizing the mixing apparatus; and a resultant viscous flowable product of improved and specified consistency and texture, such as a mayonnaise, mayonnaise-type emulsion or salad dressing formulated through the mixing apparatus and method.
Michael D. Major - Evanston IL, US David W. Moore - Hebron IL, US
Assignee:
ANGUS CHEMICAL COMPANY - Buffalo Grove IL
International Classification:
C07C 209/34
US Classification:
564511
Abstract:
Provided is a process for preparing alkyl diamine compounds in high purity. The process utilizes an alkyl amine compound during the reduction of a nitroamine, resulting in reduction of the concentration of undesired byproducts.
Process And Apparatus For Production And Filtration Of Aminoalcohols Using A Continuous Stirred Tank Slurry Reactor
Michael D. Major - Evanston IL, US John D. Gummere - Monroe LA, US
International Classification:
C07C 213/02 C07C 29/151 C07C 209/52
US Classification:
564373, 422147, 422187, 564503, 568863
Abstract:
Disclosed are processes and apparatuses for producing a reaction product and enabling the reaction product to be removed from a reactor operating at an elevated pressure, while simultaneously maintaining the gas pressure and retaining the catalyst inside the apparatus.